Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Brain stem cells are not rejected when transplanted

14.07.2003


Findings could improve retinal and other nervous system transplants



For the first time scientists have shown that brain stem cells are immune privileged, which means that they are invisible to a transplant recipient’s immune system and do not trigger the immune system to reject them. These results, published in the July issue of Stem Cells, indicate that using central nervous system stem cells in transplants for diseases of the eye (which is part of the brain), brain, and spinal cord, may eliminate the need for tissue typing before, and immunosuppressive drugs after, transplantation. Ultimately these findings promise to improve the success of retinal transplantation to regenerate vision for millions with macular degeneration, retinitis pigmentosa and diabetic retinopathy and brain transplants to restore functioning for patients with disorders such as Parkinson’s disease.

"These findings are very exciting," says Michael Young, PhD, the lead author of the study and an assistant scientist at Schepens Eye Research Institute and assistant professor at Harvard Medical School. "Though we suspected brain stem cells might be protected in this way, this is the first documented evidence."


Most tissues when transplanted from one body to another are seen by the recipient as foreign and attacked by the immune system. This is because the transplanted tissue has molecules on its surface called antigens that are recognized by the immune system as "not self." If the immune response goes unchecked by drugs to inhibit the attack, it will eventually destroy the transplanted tissue and reject it.

There are sites in the body that do not mount attacks against foreign tissue because to do so would be too self-destructive. For instance, in the eye an all out immune attack would cause inflammation that would destroy delicate tissue and, with it, vision. These sites, which are known as "immune privileged," include the eye, the brain, the digestive system, and the reproductive system.

Young, who in previous research found that brain and retinal stem cells transplanted into the eyes of mice and rats seemed to survive longer and integrate more easily into damaged retinas than other cells, suspected that these "neural stem cells" might be immune privileged. The only way for him to learn the true nature of their immune properties was to transplant these neural stem cells to a part of the recipients body that, unlike the eye, was not immune privileged already.

He and his colleagues chose a part of the body that always rejects transplanted tissue without immunosuppressant drugs and without close tissue typing – the kidney capsule, the pouch in which the kidney is located. This pouch is commonly used to determine whether transplants can survive. Over the years scientists have tested skin, cornea and other tissues in the kidney capsule to evaluate their transplant potential.

Young and his colleagues took brain stem cells from green mice (mice in which the gene for green protein found in jellyfish has been inserted) and placed them under the kidney capsule in other normal non-green mice. After 4 weeks, the team examined the mice and found that the stem cells had not been rejected in any of the mice, and, in fact, had grown into neural tissue.

They concluded that these neural stems cells did not induce an immune response and must be invisible to the immune system, at least initially. The next step was to determine if the cells possessed the antigens that most other tissues had. To test this theory, the team took other brain cells (not stem cells) from the green mice and implanted them in the normal non-green mice. These cells were rejected, and when brain stem cells were then again implanted in the normal non-green mice, they, too were rejected. The team concluded, therefore, that the brain stem cells did possess antigens, but unless the recipient was primed or pre-immunized, the antigens were not visible to the immune system of the recipient and not rejected.

"Understanding the immune properties of these stem cells could have an enormous effect on how we perform brain or retinal transplantations in the future. Stem cells already have the advantage of being able to transform or differentiate into various types of cells and can be reproduced endlessly outside the body. Now we know that at least brain stem cells are immune privileged and can be used without the same worry about tissue matching or immunosuppression that is true for other types of tissue. Young is the director of Schepens Eye Research Institute’s Minda de Gunzburg Retinal Transplantation Research Center. The center is committed, with a focus on retinal regeneration, to unlocking the mysteries of vision and finding the cures for blinding eye diseases that devastate millions in the United States and around the world.

The study, titled "Neural progenitor cells lack immunogenicity and resist destruction as allografts" can be obtained at the Stems Cells website at http://stemcells.alphamedpress.org/ or by emailing pattijacobs@hotmail.com or mikey@vision.eri.harvard.edu.

Other members of the research team include Junko Hori, Tat Fong Ng, Marie Shatos, and J. Wayne Streilein of Schepens Eye Research Institute of Boston and Henry Klassen of the Stem Cell Research Program at Children’s Hospital of Orange County in Orange, California.


###
Schepens Eye Research Institute is an affiliate of Harvard Medical School and is the largest independent eye research institute in the world.


Patti Jacobs | EurekAlert!
Further information:
http://www.eri.harvard.edu/
http://stemcells.alphamedpress.org/

More articles from Life Sciences:

nachricht New risk factors for anxiety disorders
24.02.2017 | Julius-Maximilians-Universität Würzburg

nachricht Stingless bees have their nests protected by soldiers
24.02.2017 | Johannes Gutenberg-Universität Mainz

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Stingless bees have their nests protected by soldiers

24.02.2017 | Life Sciences

New risk factors for anxiety disorders

24.02.2017 | Life Sciences

MWC 2017: 5G Capital Berlin

24.02.2017 | Trade Fair News

VideoLinks
B2B-VideoLinks
More VideoLinks >>>